Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats

Journal of Trace Elements in Medicine and Biology

Volumn 17, Issue 4, 2004, Pages 243-247

  Kim, Dong Sun ^a   Kim, Tae Wha ^a   Kang, Ju Seop ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Chromium; Diabetes; Goto Kakizaki; Insulin sensitivity; Rats

Indexed keywords

CHROMIUM PICOLINATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFECT; GLUCOSE TOLERANCE TEST; INJECTION; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; WEIGHT GAIN;

ANIMALIA;

EID: 1942534587     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0946-672X(04)80025-7     Document Type: Article

References (26)

1. Schwarz K, and Mertz W (1959) Chromium(III) and glucose tolerance factor. Arch. Biochem Biophys 85: 292-295
2. Striffler JS, Polansky MM, and Anderson RA (1988) Dietary chromium decreases insulin resistance in rats fed a high-fat, mineral-imbalanced diet. Metabolism 47: 396-400
3. Lee NA, and Reasner CA (1994) Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17: 1449-1452
4. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, and Bruce-Robertson A (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30: 531-538
5. Brown RO, Forloines-Lynn S, Cross RE, and Heizer WD (1986) Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci 32: 661-664
6. Striffler JS, Polansky MM, and Anderson RA (1999) Overproduction of insulin in the chromium-deficient rat. Metabolism 48: 1063-1068
7. Uusitupa MI, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyorala KP, Koivistoinen PE, and Lehto JT (1983) Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in non-insulin-dependent diabetics. Am J Clin Nutr 38: 404-410
8. Abraham AS, Brooks BA, and Eylath U (1992) The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metab Clin Exp 41: 768-771
9. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, and Feng J (1997) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46: 1786-1791
10. Elias AN, Grossman MK, and Valenta LJ (1984) Use of the artificial beta cell (ABC) in the assessment of peripheral insulin sensitivity: Effect of chromium supplementation in diabetic patients. Gen Pharmacol 15: 535-539
11. Lukaski HC (1999) Chromium as supplement. Ann Rev Nutr 19: 279-301
12. Anderson RA (1995) Chromium and parenteral nutrition. Nutrition 11: 83-86
13. Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, and Gray TA (1999) Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol 13: 57-61
14. Striffler JS, Law JS, Polansky MM, Bhathena SJ, and Anderson RA (1995) Chromium improves insulin response to glucose in rats. Metabolism 44: 1314-1320
15. Goto Y, Suzuki K, Ono T, and Toyota M (1988) Development of diabetes in the non-obese NIDDM rat (GK rat). Adv Exp Med Biol 246: 29-31
16. Anderson RA, Bryden NA, and Polansky MM (1997) Lack of toxicity of chromium chloride and chromium picolinate in rat. J Am Coll Nutr 16: 273-279
17. Trow LG, Lewis J, Greenwood RH, Sampson MJ, Self KA, Crews HM, and Fairweather-Tait SJ (2000) Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin, and lipoprotein levels in patients with type 2 diabetes. Int J Vitam Nutr Res 70: 14-18
18. Doisy RJ, Streeten DHP, Freiberg JM, and Schneider AJ (1976) Chromium metabolism in man and biochemical effects. In: Prasad AS, Oberleas D (Eds) Trace Elements in Human Health and Disease: Essential and Toxic Elements. Marcel Dekker, New York
19. Tuman RW, Bilbo JT, and Doisy RJ (1978) Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice. Diabetes 27: 49-56
20. Vincent JB (2000) Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Reviews 58: 67-72
21. Yamamoto A, Wada O, and Ono T (1987) Isolation of Biologically active low-molecular-mass chromium compound from rabbit liver. Eur J Biochem 165: 627-631
22. Davis CM, and Vincent JB (1997) Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 15: 4382-4385
23. Anderson RA (1998) Effects of chromium on body composition and weight loss. Nutr Rev 56: 266-270
24. Amato P, Morales AJ, and Yen SS (2000) Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol A Biol Sci Med Sci 55: 260-263
25. Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, and Terry JG (1999) Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med 12: 71-83
26. Kim DS, Kim TW, Park IK, Kang JS, and Om AS (2002) Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone treated rats. Metabolism 51: 589-594